iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: http://statista.com/statistics/448273/annual-ms-drug-costs-by-select-countries/
Annual cost of MS therapies by select countries 2013-2014 | Statista

Annual cost of MS drugs by select countries 2013-2014

Published by Statista Research Department, Apr 24, 2015
This statistic describes an annual cost comparison of multiple sclerosis (MS) drugs in the United States and other select countries, as of 2013 (or 2014). At this time, Avonex cost on average 30,273 U.S. dollars per year for the U.S. Department of Veterans Affairs and 18,641 U.S. dollars in Canada.

Multiple sclerosis drug annual cost in selected countries in 2013/2014 (in U.S. dollars)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

April 2015

Region

Worldwide, United States

Survey time period

2013 and 2014

Supplementary notes

MS: multiple sclerosis
Further sources: Pharmaceutical Benefits Scheme (Australia), Ontario Ministry of Health and Long-Term Care (Canada), British National Formulary (UK).
* Interfereon-ß-1b is marketed as Betaseron (Bayer) and Extavia (Novartis).
** Natalizumab was withdrawn from the market in February 2005 to evaluate progressive multifocal leukoencephalopathy risk and was reintroduced in June 2006.
*** Price pending in Canada.

Open this statistic in...
Spanish
Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Drug prices in the U.S. "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Drug prices in the U.S.

Market overview

7

United States vs. abroad

7

Price increase

7

Biosimilars' effects

5

Consumers' views

5

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical market in ThailandDemographics of ThailandHealth in ThailandMedical device industry in ThailandCoronavirus (COVID-19) pandemic in Thailand
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.